A new study identifies the mechanism for tolerance to penicillin and related antibiotics in bacteria, findings that could lead to new therapies that boost the effectiveness of these treatments.

The Office of Academic Integration has awarded $750,000 in seed grants to 10 studies ranging from refugee health and legal rights, to a vaccine treating fentanyl addiction and overdose, to pancreatic cancer and…

The discovery of a weakness in a gut bacteria that causes intestinal inflammation may lead to more targeted therapies for the disease, researchers have found.

Academic Integrations awards $750,000 in Multi-Investigator Seed Grants supporting ten intercampus research projects and opens a new RFA for 2021 Multi-Investigator Seed Grants.

The Office of Academic Integration is pleased to introduce the 2020 Multi-Investigator Seed Grant awardees. These awardees represent diverse collaborative research projects from 5 schools and 18 departments/divisions…

A Cornell-led COVID-19 patient registry, organized by Weill Cornell Medicine physicians and scientists continues to be a source of medical insight into the workings of the novel coronavirus and treatment…

Marcos Simoes-Costa in the Department of Molecular Biology and Genetics, and Dan A. Landau with Weill Cornell Medicine have both been awarded $600,000 from the Sontag Foundation to advance their research into brain…

The “One Health” approach is perfectly suited to tackling the COVID-19 pandemic, the most serious public health crisis in recent history, Cornell researchers said during the university’s COVID-19 Summit, a virtual…

Cornell researchers are working collaboratively at the forefront of their fields to re-examine and adapt their innovations to develop the tests, treatments and knowledge necessary to end the COVID-19 pandemic.

An intercampus research team has been awarded a five-year, $3.65 million grant from the National Institutes of Health to develop a quick, inexpensive method for accurately diagnosing urinary tract infections in kidney…

Researchers across the university’s colleges and campuses have been collaborating to better understand the virus at the center of this global pandemic, with the aim of treatment and containment.

Intercampus research led by Dr. Barbieri's lab at Weill Cornell Medicine, performed the first comprehensive molecular investigation of the overgrowth, called benign prostatic hyperplasia (BPH).

Collaborating across disparate disciplines to tackle the grand challenges facing humanity is intrinsic to Cornell’s unique brand of research innovation. Cornell blends the intellectual capital and academic distinction…

More than 50 doctors, nurses and other health care professionals from Cayuga Health in Ithaca have joined their Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center counterparts to care for New…

More than three years into the provost’s Radical Collaboration initiative, partnerships continue to spark research and bold approaches into new areas.

Students, faculty, staff, alumni and community members are working together around the clock to 3D print protective visors for medical workers at Weill Cornell Medicine and local hospitals.

Letter from Vice Provost Koretzky regarding the impact of COVID on the Multi-Investigator Seed Grant RFA.

Urinary tract infections in kidney transplant patients may be caused by bacteria that originate in the digestive tract, according to researchers at Weill Cornell Medicine.